Condition: Recurrent or Metastatic Solid Tumors · Sponsor: Daiichi Sankyo
This study is designed to assess the efficacy and safety of ifinatamab deruxtecan (I-DXD) in the following tumor types: endometrial cancer (EC); head and neck squamous cell carcinoma (HNSCC); pancreatic ductal adenocarcinoma (PDAC); colorectal cancer (CRC); hepatocellular carcinoma (HCC); adenocarcinoma of esophagus, gastroesophageal junction, and stomach (Ad-Eso/GEJ/gastric); urothelial carcinoma (UC); ovarian cancer (OVC); cervical cancer (CC); biliary tract cancer (BTC); human epidermal growth factor 2 (HER2)-low breast cancer (BC); HER2 immunohistochemistry (IHC) 0 BC; and cutaneous melanoma.
This description comes directly from the study's public registry record.
(US) Daiichi Sankyo Contact for Clinical Trial Information · 9089926400 · CTRinfo@dsi.com
(Asia) Daiichi Sankyo Contact for Clinical Trial Information · +81-3-6225-1111 (M-F 9-5 JST · dsclinicaltrial@daiichisankyo.co.jp
Always discuss trial participation with your own doctor first.
| Los Angeles Cancer Network | Los Angeles, California, United States | Recruiting |
| Valkyrie Clinical Trials | Los Angeles, California, United States | Active Not Recruiting |
| Pih Health Hematology Medical Oncology | Whittier, California, United States | Recruiting |
| Orchard Healthcare Research Inc. | Skokie, Illinois, United States | Recruiting |
| M Health Fairview University of Minnesota Medical Center | Minneapolis, Minnesota, United States | Recruiting |
| NYU Langone Health | New York, New York, United States | Recruiting |
| Icahn School of Medicine At Mount Sinai Prime | New York, New York, United States | Recruiting |
| Clinical Research Alliance | Westbury, New York, United States | Recruiting |
| Tn Gynecologic Oncology Group, Llc | Chattanooga, Tennessee, United States | Recruiting |
| The West Clinic | Germantown, Tennessee, United States | Recruiting |
| SCRI Oncology Partners | Nashville, Tennessee, United States | Recruiting |
| Texas Oncology - West Texas | Amarillo, Texas, United States | Recruiting |
+ 107 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06330064